Continental Chemicals has filed a statement regarding the utilization of funds raised through a preferential issue. The company secured 1.625 Cr on 14/10/2019, specifically earmarked for working capital. The funds were fully utilized as intended by the quarter ending 31/12/2023, with no deviation or variation from the original objectives. The Audit Committee has reviewed and approved this utilization report, providing shareholders with clarity on how the capital was deployed.